Abstract
EUCAST ciprofloxacin area of technical uncertainty in Escherichia coli and Klebsiella pneumoniae using BD Phoenix™ and VITEK® 2 automated susceptibility systems.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have